Immune-mediated epilepsies

Epilepsia

Volumn 52, Issue SUPPL. 3, 2011, Pages 5-11

  Granata, Tiziana ^a   Cross, Helen ^b   Theodore, William ^c   Avanzini, Giuliano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Hemiconvulsion hemiplegia; Immune mediated disease; Infantile spasms; Inflammation; Rasmussen's encephalitis; Temporal lobe epilepsy

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIBODY; CORTICOTROPIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; T LYMPHOCYTE ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CONTINUOUS SPIKE WAVES DURING SLEEP; EPILEPSY; EPILEPTOGENESIS; HEMICONVULSION HEMIPLEGIA SYNDROME; IMMUNOMODULATION; INFANTILE SPASM; INFLAMMATION; INNATE IMMUNITY; LANDAU KLEFFNER SYNDROME; NEURONAL CEROID LIPOFUSCINOSIS; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RASMUSSEN SYNDROME; SEIZURE; T LYMPHOCYTE ACTIVATION; TEMPORAL LOBE EPILEPSY; VIRUS INFECTION; WEST SYNDROME;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; ENCEPHALITIS; EPILEPSY; HUMANS; INFLAMMATION MEDIATORS;

EID: 79955677464     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03029.x     Document Type: Article

References (43)

1. Auvin S, Devisme L, Maurage CA, Soto-Ares G, Cuisset JM, Leclerc F, Vallee L,. (2007) Neuropathological and MRI findings in an acute presentation of hemiconvulsions-hemiplegia: a report with pathophysiological implications. Seizure 16: 371-376. (Pubitemid 46614653)
2. Baram TZ, Schultz L,. (1991) Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61: 97-101.
3. Baram TZ, Mitchell WG, Snead OC 3rd, Horton EJ, Saito M,. (1992) Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 42: 1171-1175.
4. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG,. (2007) Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 62: 67-80. (Pubitemid 47235282)
5. Berg AT, Berkovic SF, Brodie MJ, Buchhalter JR, Cross JH, Van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE,. (2010) Revised terminology and concepts for organisation of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51: 676-685.
6. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H,. (2002) Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 51: 311-318. (Pubitemid 34206287)
7. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE,. (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128: 454-471. (Pubitemid 40380182)
8. Bien CG, Urbach H, Schramm J, Soeder BM, Becker AJ, Voltz R, Vincent A, Elger CE,. (2007) Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69: 1236-1244. (Pubitemid 47429024)
9. Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ,. (2001) Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin- releasing hormone gene expression. Ann Neurol 49: 304-312. (Pubitemid 32202783)
10. Brunson KL, Avishai-Eliner S, Baram TZ,. (2002) ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 49: 185-197.
11. Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA,. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11: 1421-1431.
12. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30: 389-399.
13. Fayad MN, Choueiri R, Mikati M,. (1997) Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia 38: 489-494. (Pubitemid 27172031)
14. Freeman JL, Coleman LT, Smith LJ, Shield LK,. (2002) Hemiconvulsion, hemiplegia-epilepsy syndrome: characteristic early magnetic resonance imaging findings. J Child Neurol 17: 10-16. (Pubitemid 34406879)
15. Friedman A, Dingledine R,. (2011) Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 52 (Suppl. 3): 33-38.
16. Galanopoulou AS, Bojko A, Lado F, Moshé SL,. The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 2000; 22: 279-295. (Pubitemid 30417428)
17. Gastaut H, Poirier F, Payan H, Salamon G, Toga M, Vigouroux M,. (1960) H.H.E. syndrome; hemiconvulsions, hemiplegia, epilepsy. Eksp Khirurgiia 1: 418-447.
18. Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac R, Kröll-Seger J, Kurlemann G, Makowski C, Rostasy K, Tuschen-Hofstätter E, Weber G, Vincent A, Bien CG,. (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96: 186-191.
19. Haginoya K, Noguchi R, Zhao Y, Munakata M, Yokoyama H, Tanaka S, Hino-Fukuyo N, Uematsu M, Yamamoto K, Takayanagi M, Iinuma K, Tsuchiya S,. (2009) Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res 85: 314-317.
20. Hirsch E, Valenti MP, Rudolf G, Seegmuller C, de Saint Martin A, Maquet P, Wioland N, Metz-Lutz MN, Marescaux C, Arzimanoglou A,. (2006) Landau-Kleffner syndrome is not an eponymic badge of ignorance. Epilepsy Res 70 (suppl 1): S239-S247.
21. JoÃls M, Baram TZ,. (2009) The neuro-symphony of stress. Nat Rev Neurosci 10: 459-466.
22. Kitamura D, Roes J, Kuhn R, Rajewsky K,. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426. (Pubitemid 21912244)
23. Kovacs AD, Pearce DA,. (2008) Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Exp Neurol 209: 288-291.
24. Landau W, Kleffner FR,. (1957) Syndrome of acquired aphasia with convulsive disorder in children. Neurology 7: 523-530.
25. Lim MJ, Beake J, Bible E, Curran TM, Ramirez-Montealegre D, Pearce DA, Cooper JD,. (2006) Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 32: 469-482. (Pubitemid 44401509)
26. Lim MJ, Alexander N, Benedict JW, Chattopadhyay S, Shemilt SJ, Guerin CJ, Cooper JD, Pearce DA,. (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 25: 239-251. (Pubitemid 46138045)
27. Liu ZS, Wang QW, Wang FL, Yang LZ,. (2001) Serum cytokine levels are altered in patients with West syndrome. Brain Dev 23: 548-551.
28. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG,. (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67: 470-478.
29. Mitchison HM, Bernard DJ, Greene ND, Cooper JD, Junaid MA, Pullarkat RK, de Vos N, Breuning MH, Owens JW, Mobley WC, Gardiner RM, Lake BD, Taschner PE, Nussbaum RL,. (1999) Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium. Neurobiol Dis 6: 321-334. (Pubitemid 29496212)
30. Nevsímalová S, Tauberová A, Doutlík S, Kucera V, Dlouhá O,. (1992) A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome? Brain Dev 14: 342-345.
31. Provenzale JM, Barboriak DP, VanLandingham K, MacFall J, Delong D, Lewis DV,. (2008) Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis. Am J Roentgenol 190: 976-983. (Pubitemid 351571519)
32. Rashid W, Miller DH,. (2008) Recent advances in neuroimaging of multiple sclerosis. Semin Neurol 28: 46-55. (Pubitemid 351273083)
33. Rasmussen T, Olszewski L, Lloyd-Smith D,. (1958) Focal seizures due to chronic localized encephalitis. Neurology 8: 435-445.
34. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO,. (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265: 648-651.
35. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, Wiendl H,. (2009) CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 132: 1236-1246.
36. Seehafer SS, Ramirez-Montealegre D, Wong AM, Chan CH, Castaneda J, Horak M, Ahmadi SM, Lim MJ, Cooper JD, Pearce DA,. (2010) Immunosuppression alters disease severity in juvenile Batten disease mice. J Neuroimmunol 230: 169-172.
37. Stoll G, Bendszus M,. (2009) Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 158: 1151-1160.
38. Tassinari CA, Rubboli G, Volpi L, Meletti S, d'Orsi G, Franca M, Sabetta AR, Riguzzi P, Gardella E, Zaniboni A, Michelucci R,. (2000) Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin Neurophysiol 111 (suppl 2): S94-S102.
39. Tekgul H, Polat M, Tosun A, Serdaroglu G, Kutukculer N, Gokben S,. (2006) Cerebrospinal fluid interleukin-6-levels in patients with West syndrome. Brain Dev 28: 19-23. (Pubitemid 43042433)
40. The International Batten Disease Consortium. (1995) Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 82: 949-957.
41. Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacoboson S,. (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49: 1828-1837.
42. Vincent A, Irani SR, Lang B,. (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 23: 144-150.
43. Weimer JM, Custer AW, Benedict JW, Alexander NA, Kingsley E, Federoff HJ, Cooper JD, Pearce DA,. (2006) Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiol Dis 22: 284-293.